SCHEMBL3198497

SCHEMBL3198497

C#CCOc1cccc(OCC#C)c1OCC#C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.49
CYP2A6 P11509 1/20 0.49
MAPT P10636 1/20 0.47
MAOB P27338 6/20 0.46
LOXL2 Q9Y4K0 1/20 0.41
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TXNRD1 Q16881 1/20 0.39
TXNRD3 Q86VQ6 1/20 0.39
TXNRD2 Q9NNW7 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOA P21397 3/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
ALOX15 P16050 1/20 0.37
ACHE P22303 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16774381 0.86 CYP3A4 (0.43) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL5685999 0.85 SMN1; SMN2 (0.59) CYP3A4CYP2A6MAPTPOLBMAPK1
SCHEMBL10347560 0.83 MAPT (0.56) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL30663731 0.83 MAPT (0.56) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL4090880 0.82 SMN1; SMN2 (0.50) CYP3A4CYP2A6MAPTMAOBPOLB
SCHEMBL19038909 0.82 CYP3A4 (0.57) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL10517952 0.82 MAOB (0.56) CYP3A4CYP2A6MAPTMAOBMAPK1
Hydrochloric Acid SCHEMBL21694039 0.81 MAPT (0.55) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL19616353 0.80 MAPT (0.48) CYP3A4CYP2A6MAPTMAOBLOXL2
SCHEMBL10638648 0.79 RAB9A (0.51) CYP3A4CYP2A6MAPTPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9333150-B2 Dental restorative materials based on polymerizable azides and alkynes IVOCLAR VIVADENT AG (LI) 2016-05-10 US disclosed
US-9333150-B2 Dental restorative materials based on polymerizable azides and alkynes IVOCLAR VIVADENT AG (LI) 2016-05-10 US disclosed
US-20140171536-A1 Dental Restorative Materials Based on Polymerizable Azides and Alkynes IVOCLAR VIVADENT AG (LI) 2014-06-19 US disclosed
US-20140171536-A1 Dental Restorative Materials Based on Polymerizable Azides and Alkynes IVOCLAR VIVADENT AG (LI) 2014-06-19 US disclosed
EP-2743267-A1 Dental materials based on polymerisable azides and alkenes Ivoclar Vivadent AG (LI) 2014-06-18 EP disclosed
US-8101238-B2 Polymeric materials via click chemistry THE SCRIPPS RESEARCH INSTITUTE (US) 2012-01-24 US disclosed
US-8101238-B2 Polymeric materials via click chemistry THE SCRIPPS RESEARCH INSTITUTE (US) 2012-01-24 US disclosed
US-20100029888-A1 Click-Reaction Crosslinkable Multicomponent Silicone Compositions WACKER CHEMIE AG (DE) 2010-02-04 US disclosed
US-20080311412-A1 Polymeric Materials Via Click Chemistry THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-18 US disclosed
US-20080311412-A1 Polymeric Materials Via Click Chemistry THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-18 US disclosed
EP-0249567-A2 Propargyloxybenzene derivatives, their preparation and fungicidal compositions containing them RHONE-POULENC AGROCHIMIE (FR) 1987-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171536-A1 Dental Restorative Materials Based on Polymerizable Azides and Alkynes PRXL2A, CNPY2, CDYL CYP3A4 4366/4885CYP2A6 3479/4885MAPT 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.